✦ LIBER ✦

Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

✍ Scribed by Gomez-Martin, C.; Plaza, J. C.; Pazo-Cid, R.; Salud, A.; Pons, F.; Fonseca, P.; Leon, A.; Alsina, M.; Visa, L.; Rivera, F.; Galan, M. C.; del Valle, E.; Vilardell, F.; Iglesias, M.; Fernandez, S.; Landolfi, S.; Cuatrecasas, M.; Mayorga, M.; Jose Paules, M.; Sanz-Moncasi, P.; Montagut, C.; Garralda, E.; Rojo, F.; Hidalgo, M.; Lopez-Rios, F.

Book ID: 121407652
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 485 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.48.9070

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Level of HER2/neu amplification in prima

Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy

✍ Gullo, Giuseppe; Bettio, Daniela; Zuradelli, Monica; Masci, Giovanna; Giordano, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phosphorylated HER-2 tyrosine kinase and

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

✍ Rosa Giuliani; Virginie Durbecq; Angelo Di Leo; Marianne Paesmans; Denis Larsimo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 636 KB

A decline in circulating HER2 DNA predic

A decline in circulating HER2 DNA predicts treatment response and survival in breast cancer patients treated with trastuzumab

✍ B. Sorensen; L.S. Mortensen; J. Andersen; E. Nexo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 88 KB

5089 Shorter Overall Survival (OS) in HE

5089 Shorter Overall Survival (OS) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T)± chemotherapy (CT) and overexpressing HER3 by immunohistochemistry (IHC)

✍ S. Gori; A. Sidoni; M. Colozza; M.G. Mameli; D. Fenocchio; E. Minenza; J. Foglie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Serum CD44 levels and overall survival i

Serum CD44 levels and overall survival in patients with HER2-positive breast cancer

✍ Jong-Min Baek; Quanri Jin; Joe Ensor; Delphine R. Boulbes; Francisco J. Esteva 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 201 KB

The level of HER2/neu gene amplification

The level of HER2/neu gene amplification as predictive factor in patients with metastatic breast cancer treated with a trastuzumab-based therapy

✍ G. Gullo; D. Bettio; V. Torri; G. Masci; P. Salvini; A. Santoro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB